Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
7,785,907
-
Shares change
-
+101,367
-
Total reported value, excl. options
-
$72,596,741
-
Value change
-
-$2,908,464
-
Put/Call ratio
-
43%
-
Number of buys
-
32
-
Number of sells
-
-25
-
Price
-
$9.33
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q3 2021
85 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2021.
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,785,907 shares
of 56,066,823 outstanding shares and own 13.89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,959,438 shares), VANGUARD GROUP INC (1,592,868 shares), STATE STREET CORP (546,549 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (501,931 shares), GEODE CAPITAL MANAGEMENT, LLC (488,732 shares), BOOTHBAY FUND MANAGEMENT, LLC (412,416 shares), Janney Montgomery Scott LLC (279,440 shares), NORTHERN TRUST CORP (262,898 shares), GOLDMAN SACHS GROUP INC (168,689 shares), and RENAISSANCE TECHNOLOGIES LLC (165,600 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.